InsidersTradesSigma
Iovance Biotherapeutics, INC.: insider trades · United States · SEC (Form 4)
SEC:iovance-biotherapeutics-inc-9db83dUS·SEC (Form 4)
Discover the full insider trade history of Iovance Biotherapeutics, INC., a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 16 June 2022 (Levée d'options). Among the most active insiders: BILINSKY IGOR. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
€3m
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
3.58 €
Analyst consensus
Valuation
P/Book2.2x
Beta0.69
Balance sheet & cash
Debt / Equity7%
Profitability & ownership
ROE-47.5%
ROA-23.6%
% insiders0.3%
% institutions67.4%
Last declaration on 16 June 2022
Declarations0 total
No declarations found
0 of 0 declarations